Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
K062864Substantially Equivalent

Mastalex -Mrsa, Model Rst501

Mast Group Ltd., Bootle, Merseyside, GB / Traditional, Substantially Equivalent

K062864 is the FDA 510(k) clearance record for MASTALEX -MRSA, MODEL RST501, a class II device, cleared for Mast Group , Ltd. on under FDA product code MYI (System, Test, Genotypic Detection, Resistant Markers, Staphylococcus Colonies). FDA records list one 510(k) clearance for Mast Group , Ltd. As of , FDA records show no recalls naming K062864.

Clearance record

Decision date
Received
(23 days to decision)
Product code
MYI System, Test, Genotypic Detection, Resistant Markers, Staphylococcus Colonies
Regulation
21 CFR 866.1640
Device class
Class II
Review panel
Microbiology
Applicant
Mast Group , Ltd. Mast House, Derby Rd., Bootle, Merseyside, GB
510(k) summary
Summary PDF
Third party review
No

Clearances, product code MYI

Trailing 12 months

FDA records hold no clearances under product code MYI in the trailing twelve months.

FDA records show no clearances under product code MYI in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code MYI, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260